NRX Pharmaceuticals, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
NRXP, NRXPW on Nasdaq
Industry
Pharmaceutical Preparations
Location
1201 Orange Street, Suite 600, Wilmington, DE

There are no Buy or Sell transactions made by insiders since 10/6/2023

NRX Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jonathan C. Javitt Chief Scientist, Director, 10%+ Owner $4.72M Aug 23, 2023
Daniel Javitt 10%+ Owner $3.08M Nov 29, 2022
Chaim Hurvitz Director $709K Aug 30, 2023
Big Rock Partners Sponsor, LLC 10%+ Owner $266K May 24, 2021
BRAC Lending Group LLC 10%+ Owner $189K May 24, 2021
Robert Besthof Interim CEO $57K Mar 8, 2022
William Fricker CFO & Treasurer $39.7K May 24, 2021
Aaron Gorovitz Director $33.6K Aug 30, 2023
Daniel Troy Director $26.9K May 24, 2021
Stephen Willard CHIEF EXECUTIVE OFFICER, Director $16K Dec 16, 2022
Alessandra Daigneault General Counsel & Secretary $15.9K Aug 19, 2021
Seth Van Voorhees Chief Financial Officer $14.8K Dec 16, 2022
Patrick J. Flynn Director $13.4K Nov 28, 2022
Herbert Raymond McMaster Director $9.13K Aug 26, 2021
Janet Rehnquist Director Dec 28, 2023
Richard Narido Interim CFO Sep 13, 2023
Sharon Glied Director Oct 21, 2022
Ira S. Strassberg Chief Financial Officer Mar 15, 2022
Dennis McBride Director Jun 13, 2024

Recent Insider Transactions by Companies or Individuals for NRX Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.